F MUELLER: Open Payments
NPI 1497763080 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 56 payments from 7 companies in 2025. Trend: 2023 $1,280 · 2024 $1,292 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $439 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $406 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Alkermes, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, FANAPT.
Industry payments across CT — which companies pay providers there.
